- Exchange: NASDAQ CM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Catalyst Pharmaceutical Partners Inc+ Add to Watchlist
CPRX:US2.9600 USD 0.0600 2.07%
As of 20:10:00 ET on 12/26/2014.
Company Profile for Catalyst Pharmaceutical Partners Inc (CPRX)
Catalyst Pharmaceutical Partners, Inc. is a pharmaceutical company focused on the development and commercialization of prescription drugs for the treatment of addiction. The Company develops drugs for addictions such as methamphetamine, nicotine, prescription pain medications, alcohol, and marijuana, as well as treatments for related addictive disorders, such as obesity and gambling.
Catalyst Pharmaceutical Partners Inc
Key Executives for Catalyst Pharmaceutical Partners Inc (CPRX)
|Patrick J McEnanyChairman/President/CEO/Co-Founder||Steven R MillerChief Operating Officer|
|Charles W GorodetzkyChief Medical Officer||David D MuthExec VP:Corporate Development|
|Alicia GrandeVP/CFO/Treasurer||Bernardino MosqueraVP:Clinical Operations|
|M Douglas WinshipVP:Regulatory Operations|